H.C. Geiss

2.7k total citations
23 papers, 476 citations indexed

About

H.C. Geiss is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, H.C. Geiss has authored 23 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cancer Research. Recurrent topics in H.C. Geiss's work include Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (5 papers). H.C. Geiss is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Cancer, Lipids, and Metabolism (5 papers). H.C. Geiss collaborates with scholars based in Germany. H.C. Geiss's co-authors include P. Schwändt, Klaus G. Parhofer, Carsten Otto, Werner Richter, Robert J. Frost, Michael M. Ritter, C. Otto, Markus G. Donner, Andreas Sönnichsen and Anthony R. Tricker and has published in prestigious journals such as Journal of the American College of Cardiology, Hepatology and Analytical Biochemistry.

In The Last Decade

H.C. Geiss

22 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.C. Geiss Germany 14 340 220 95 90 51 23 476
Howard M. Monroe United States 5 325 1.0× 274 1.2× 123 1.3× 132 1.5× 63 1.2× 6 598
Angelique C.M. Jansen Netherlands 11 460 1.4× 245 1.1× 181 1.9× 136 1.5× 46 0.9× 12 644
B. O'Connor United Kingdom 10 247 0.7× 216 1.0× 51 0.5× 114 1.3× 15 0.3× 16 481
Paolo Pauciullo Italy 14 302 0.9× 212 1.0× 66 0.7× 281 3.1× 27 0.5× 34 624
James K. Fleming United States 9 287 0.8× 251 1.1× 57 0.6× 97 1.1× 45 0.9× 15 568
Hans J. Avis Netherlands 12 496 1.5× 239 1.1× 123 1.3× 136 1.5× 90 1.8× 18 630
Harald Elster Germany 5 243 0.7× 147 0.7× 67 0.7× 146 1.6× 17 0.3× 5 365
Vasilisa Sazonov United States 13 315 0.9× 191 0.9× 34 0.4× 128 1.4× 143 2.8× 23 526
Franz Harnoncourt Austria 4 229 0.7× 89 0.4× 62 0.7× 48 0.5× 41 0.8× 6 411
Э. Г. Волкова Russia 3 288 0.8× 303 1.4× 88 0.9× 199 2.2× 23 0.5× 7 627

Countries citing papers authored by H.C. Geiss

Since Specialization
Citations

This map shows the geographic impact of H.C. Geiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.C. Geiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.C. Geiss more than expected).

Fields of papers citing papers by H.C. Geiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.C. Geiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.C. Geiss. The network helps show where H.C. Geiss may publish in the future.

Co-authorship network of co-authors of H.C. Geiss

This figure shows the co-authorship network connecting the top 25 collaborators of H.C. Geiss. A scholar is included among the top collaborators of H.C. Geiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.C. Geiss. H.C. Geiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Geiss, H.C., et al.. (2004). Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins. Atherosclerosis. 180(1). 107–112. 19 indexed citations
3.
Geiss, H.C., et al.. (2003). Influence of Etofibrate on LDL-Subtype Distribution in Patients with Diabetic Dyslipoproteinemia. Experimental and Clinical Endocrinology & Diabetes. 111(6). 322–324. 6 indexed citations
4.
Empen, Klaus, H.C. Geiss, Michael Lehrke, et al.. (2003). Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia. Nutrition Metabolism and Cardiovascular Diseases. 13(2). 87–92. 13 indexed citations
5.
Parhofer, KG, et al.. (2002). Einfluss einer verbesserten Blutzuckereinstellung auf den Lipidspiegel bei Patienten mit Typ-2-Diabetes. DMW - Deutsche Medizinische Wochenschrift. 127(18). 958–962. 4 indexed citations
7.
Geiss, H.C., Carsten Otto, P. Schwändt, & Klaus G. Parhofer. (2001). Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects. Metabolism. 50(8). 983–988. 34 indexed citations
8.
Frost, Robert J., Carsten Otto, H.C. Geiss, P. Schwändt, & Klaus G. Parhofer. (2001). Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. The American Journal of Cardiology. 87(1). 44–48. 110 indexed citations
9.
Parhofer, Klaus G., H.C. Geiss, & P. Schwändt. (2000). Efficacy of Different Low‐Density Lipoprotein Apheresis Methods. Therapeutic Apheresis. 4(5). 382–385. 31 indexed citations
10.
Otto, Carsten, H.C. Geiss, Markus G. Donner, Klaus G. Parhofer, & P. Schwändt. (2000). Influence of Atorvastatin Versus Simvastatin on Fibrinogen and Other Hemorheological Parameters in Patients with Severe Hypercholesterolemia Treated with Regular Low‐Density Lipoprotein Immunoadsorption Apheresis. Therapeutic Apheresis. 4(3). 244–248. 6 indexed citations
11.
Geiss, H.C., Klaus G. Parhofer, & P. Schwändt. (2000). Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Atherosclerosis. 151(1). 36–36. 1 indexed citations
12.
Schwändt, P., H.C. Geiss, Michael M. Ritter, et al.. (1999). The Prevention Education Program (PEP). A Prospective Study of the Efficacy of Family-Oriented Life Style Modification in the Reduction of Cardiovascular Risk and Disease. Journal of Clinical Epidemiology. 52(8). 791–800. 43 indexed citations
13.
Geiss, H.C., et al.. (1999). Low Density Lipoprotein Apheresis by Membrane Differential Filtration (Cascade Filtration). Therapeutic Apheresis. 3(3). 199–202. 21 indexed citations
14.
Geiss, H.C., Klaus G. Parhofer, & P. Schwändt. (1999). Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis. Journal of Internal Medicine. 245(1). 47–55. 15 indexed citations
15.
Geiss, H.C., et al.. (1998). Myocardial perfusion before and after single routine LDL-apheresis. Journal of the American College of Cardiology. 31. 23–23. 4 indexed citations
16.
Bonél, Harald, Thomas Helmberger, H.C. Geiss, et al.. (1998). Comparison of sequences for depicting bone marrow alterations in osteomyelitis applied in a low field strength magnetic resonance imaging system. Magnetic Resonance Materials in Physics Biology and Medicine. 7(1). 1–8. 6 indexed citations
17.
Ritter, Michael M., et al.. (1997). Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a). Atherosclerosis. 131(2). 243–248. 12 indexed citations
18.
Geiss, H.C., et al.. (1996). Low Lipoprotein (A) Levels During Acute Viral Hepatitis. Hepatology. 24(6). 1334–1337. 26 indexed citations
19.
Geiss, H.C., Michael M. Ritter, Werner Richter, & P. Schwändt. (1993). Determination of Apolipoprotein(a) Isoforms by Sodium Dodecyl Sulfate-Polyacrylamide Electrophoresis and Immunoblotting. Analytical Biochemistry. 213(1). 168–169. 2 indexed citations
20.
Tricker, Anthony R., et al.. (1990). The role of nitrate, nitrite and N-nitrosamines in carcinogenesis of colon tumours following ureterosigmoidostomy. Urological Research. 18(2). 123–129. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026